Intercept Withdraws Ocaliva From US, The PBC Drug’s Last Market

 
• By Mandy Jackson
  
The EU already revoked its approval of Ocaliva. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from United States